CHIEF REPORT

OBSTETRIC OUTPATIENT

Friday, February 05th 2021- Thursday, February 11th 2021

CHIEF ON DUTY

Dr. Tian Apriyanti

Dr. R Ismail Hadyathma

RESIDENTS ON DUTY

Dr. Wadhit Taubah

Dr. Aditya Rachman
Dr. M. Izwan Iqbal T.
Dr. Vicelia Patricia
Dr. Rizky Agustria
Dr. Meitry Tiara Nanda

SUPERVISOR

Dr. Hj. Putri Mirani, SpOG (K)-KFM

 OBSTETRIC OUTPATIENT
Month Total Patients
January
February
Total

RECAPITULATION OF OBSTETRICS OUTPATIENT

Physiology Patient

Pathology Patient

Lactation & Puerpural

Family Planning Oupatient

Total

RECAPITULATION OF OBSTETRICS OUTPATIENT

 TM I TM II TM III
Date Cases New Old New Old New Old
Patient Patient Patient Patient Patient Patient
Friday, Physiology
February
5th 2021
Monday, Pathology
February
8th 2021
Tuesday, Physiology
February
9th 2021
Wednesda
y, Pathology
February
10th 2021
Thursday, Physiology
February
11th 2021
Friday, Pathology
February
5th 2021
Monday, Physiology
February
8th 2021
Tuesday,
Pathology
February
9th 2021
Wednesda Physiology
y,
February Pathology
10th 2021
TOTAL
 Obstetric and gynecology patient recapitulation in fetomaternal outpatient
January – February 2021

No Month Obstetry Oncology FER Gynecology Urogynecology

1 January 19 39 28 13 2
2 February 6 10 11 0 0
total 25 49 39 13 2

RECAPITULATION FAMILY PLANNING CLINIC

Date Cases Contraception

 IUD Injection Tubectomy Counseling
Friday, February 5th 2021 Post-Partum 0 0 0 0
Post LSCS 0 0 0 0
Interval 0 0 0 0
Monday, February 8th 2021 Post-Partum 0 0 0 0
Post LSCS 0 0 0 0
Interval 0 0 0 0
Tuesday, February 9th 2021 Post-Partum 0 0 0 0
Post LSCS 0 0 0 0
Interval 0 0 0 0
Wednesday, February 10th
Post-Partum 1 0 0 0
2021
Post LSCS 0 0 0 0
Interval 0 0 0 0
Thursday, February 11st 0 0 0 0
Post-Partum
2021
Post LSCS 0 0 0 0
Interval 0 0 0 0
TOTAL 1 0 0 0

RECAPITULATION LACTATION AND PUERPURAL

 Diagnosis
Date Total
Post-partum Post LSCS

Friday, February 5th 2021 0 0 0

Monday, February 8th 2021 1 0 1

Tuesday, February 9th 2021 1 0 1

Wednesday, February 10th 2021 0 0 0

Thursday, February 11st 2021 1 0 1

Total 3 0 3
 Recapitulation patient January 2021 – February 2021

Case

IUD IUD Tubect Tubecto Implant Implant injection

Date IUD
omy my Couns migration
Disloc Postpa Post Post Postpart eling
ation rtum LSCS LSCS um

January 0 0 3 17 1 1 0 0 0

February 0 1 0 3 0 2 0 0 0
 RECAPITULATION OBSTETRIC OUTPATIENT
BASED ON DIAGNOSIS
No. of
No Case
Case

1.

2.

3.

4.

5.

6.

7.

Total
 RECAPITULATION FAMILY PLANNING AND LACTATION
AND PUERPERAL BASED ON DIAGNOSIS
Outpatient

No Diagnosis
Family Plan Lactation and P
ning uerperal

TOTAL
 OBSTETRIC OUTPATIENT REPORT
Friday, February 5th 2021

No Identity Analysis Diagnosis Procedure

1 Mrs. DEW/ 27 Y 04.02.2021  G3P0A2 16 weeks  Control ( February,
O/ 857301/ MUA Patient was consulted from internal gestational age 19th 2021)
RA ENIM/ DPR- medicine department with diagnosed  Systemic lupus  Aspilet 150 mg
EZA/ NS G3P0A2 preterm pregnancy with SLE. erythematous  CaCO3 3x1
 Hypertension stage Folid acid 1x1
Preterm History of abdominal pain (-), history II  FeSO4 1x1
pregnancy with of vaginal bleeding (-), history of  Single life fetus Vitamin D 1x4
systemic lupus amniotic fluid leakage (-). History of intrauterine
erythematous trauma (-), history of consume ICD 9
traditional medicine (-). ICD 10 99.21 – infusion of
Z3A.16 – 16 weeks therapeutic substance
Past Illness History gestational age
Patient has been diagnosed with SLE M32.9 – systemic
since 2014 and routinely consume lupus erythematous
methylprednisolone, simarc, and I10 – essential
sandimun hypertension
Physical examination Internal medicine
BP: 160/100 mmHg assessment
Obstetrical examination ( 04.02.2021)
Uterine fundal height in 1/2 umbilical- A.
symfisis( 12 cm), ballottement externa SLE
(+), FHR (+), G3P0A2
Hypertension stage II
Supporting examination
Lab result ( 04.02.2021) P/
Hb 12,2 g/dL RBC 4040/mm3 WBC HCQ 1x200 gram
9000/mm3 HT 36% PLT 214000/µL Aspilet 1x80 mg
MCV 88,9 fL MCH 30 pg MCHC 34 CaCO3 3x500 mg
g/dL RDW-CV 18,90% D/C Methylprednisolon
0/0/84/12/4 Ca 9,5 mg/dL SGOT 30 1x8 gram
U/L SGPT 15 U/L Albumin 3,0 g/dL Imuran 1x50 gram
Uric acid 6,1 gm/dL Na 132 mEg/L K Lansoprazole 1x30
4,7 mEg/L mg
Folic acid 3x5 mg
US Examination ( 05.02.2021) Methyldopa 3x25
16 weeks gestational age, SLF gram
Intrauterine OB/Gyn consult
Notching (+) bilateral
PE potention
2 Mrs. ANI/ 31 Y 04.02.2021  G3P2A0 11 weeks  Control ( March, 09th
O/ 1179919/ PA Patient was referred from Pelabuhan gestational age 2021)
LEMBANG/ DP Hospital with diagnosed G3P2A0 11  Single life fetus  Folic acid 1x1
 R-EZA/ AW weeks gestational age, with history of intrauterine  CaCO3 3x1
CMV, HSV and rubella infection in  FeSO4 1x1
Pregnancy control previous pregnancy. ICD 10 Laboratory
with HSV, CMV Z3A.11 – 11 weeks examination
and rubella History of abdominal contraction gestational age
infection in radiates to waist and become regular ICD 9
previous (-), history of leucorrhea (-), history of 99.21 – infusion of
pregnancy bloody show (-), history of abdominal therapeutic substance
massage (-). V72.62 – routine
laboratory
Past illness history examination
History of antenatal care with OB/Gyn
at Pelabuhan Hospital 1x/month

Obstetric history
1. 2013, female, preterm, 2400
gram, spontaneous delivery,
midwife, healthy
2. 2020, female, preterm, 1800
gram, Pelabuhan Hospital,
passed away ( congenital
rubella syndrome)
3. Current pregnancy

Obstetrical examination
Flat, supple, uterine fundal height in 1
fingers above symphysis, ballottement
externa (+), FHR 158x/minute

Supporting examination
Lab result ( 04.02.2021)
MCH 26 pg MCHC 34 g/dL RDW-
CV 13,80% D/C 0/4/69/22/5 SGOT 20
U/L SGPT 18 U/L BSS 76 mg/dL
Ferritin 12,60 ng/mL
Fe 66 µg/dL TiBC 360 µg/dL
Anti hiv Non reactive,HbsAg Non
reactive, VDRL non reactive
TORCH :
Toxoplasma IgG 0,10 IU/mL; IgM
0,05
Rubella IgG 233,20 IU/mL ; IgM 0,44
CMV IgG 212,30 AU/mL; IgM 0,14
US result ( 05.02.2021)
11 weeks gestational age, Single life
fetus intrauterine
3 Mrs. MAY/ 37 Y 05.02.2021  G2P1A0 24 weeks  Control ( March, 09th
O/ 421622/ PAL Patient came for pregnancy control. gestational age 2021)
EMBANG/ DP  Chronic  Methyldopa 3x500
R-EZA/AB History of abdominal contraction hypertension mg
radiates to waist and become regular
 Preterm (-), history of bloody show (-), history  Single life fetus  Aspilet 1x80 mg
pregnancy with of amniotic fluid leakage (-). intrauterine  CaCO3 3x1
hypertension Folic acid 1x1
Past illness history ICD 10
Patient admitted has diagnosed with Z3A.24 – 24 weeks ICD 9
HHD since 3 years ago, and routine gestational age 99.21 – infusion of
control with internist. Patient routinely I10 – essential therapeutic substance
consume hypertension
- Candersatan 8 mg
- Nifedipine 10 mg

Phyiscal examination
BP 130/90 mmHg
Obstetrical examination
Uterine fundal height in 1 fingers
above umbilical, ballottement externa
(+) FHR 165x/minute, contraction (-)

Supporting examination
Lab result ( 20.01.2021)
Hb 11,6 g/dL RBC 3800/mm3 WBC
12440/mm3 Ht 35% PLT 307000/µL
MCV 92,4 fL MCH 31 pg MCHC 33
g/dL RDW-CV 12,90% D/C
0/2/71/21/8 Ca 8,5 mg/dL SGOT 17
U/L SGPT 5 U/L Ureum 9 mg/dL
Creatinine 0,53 mg/dL Na 141 mEg/L
K 4,0 mEg/L Cl 111 mmol/L
US result ( 05.02.2021)
24 weeks gestational age, SLF
intrauterine
4 Mrs. LID/ 36 Y 04.02.2021  G4P3A0 34 weeks  Control ( February,
O/ 188136/ OGA Patient came for pregnancy control gestational age not 19th 2021)
N ILIR/ DPR-E in labor Laboratory
ZA/ HD History of abdominal contraction  Superimposed examination ( lipid
radiates to waist and become regular preeclampsia profile and fasting
Preterm (-), history of watery discharged (-),  Prior CS 1x ( on blood glucose)
pregnancy with history of amniotic fluid leakage (-). indication severe
hypertension and History of hypertension before preeclampsia + ICD 9
history of pregnancy (-), history of hypertension bronchial asthma) V72.62 – routine
shortness of in prior pregnancy (+), history of  Single life fetus laboratory
breath hypertension in this pregnancy (+). cephalic examination
presentation
Past illness history
Patient has been hospitalized at Moh. ICD 10
Hoesin Hospital with diagnosed Z3A.34 – 34 weeks
G4P3A0 22 weeks gestational age nor gestational age
in labor with superimposed O11.3 – pre-existing
preeclampsia + bronchiale asthma, hypertension with
SLF Intrauterine. preeclampsia ( third
 Physical examination trimester)
BP 144/100 mmHg O34.21 – maternal
Obstetrical examination care for previous CS
Uterine fundal height in 4 fingers
below xyphoid process ( 30 cm), Internal medicine
longitudinal lie, left fetal spine, assessment
cephalic, U 5/5, contraction (-), FHR A/
141x/minute Gestational
hypertension
Supporting examination
US result ( 05.02.2021) P/
34 weeks gestational age, Single life Dopamet 3x250 mg
fetus cephalic presentation ( evaluation in 2
High Pi A. Uterine bilateral weeks)
AC > 94,8%
Advice : lipid and glucose profile
examination

Monday, February 8th 2021

No Identity Analysis Diagnosis Procedure

1 Mrs. RUS/ 32 08.02.2021  G3P2A0 34 weeks Hospitalized
YO/ 1197006/ Patient came to fetomaternal clinic for gestational age no Plan for cystoscopy
PALEMBANG/ pregnancy control. Reffered from Dr. H t in labor Shift DIC to Dr. H.
MTN-TIA/HD adrians Kesuma Putra,OB/Gyn (C)- Uro  Placenta accrete Abarham
gyn with diagnosed G3P2A0 34 weeks g was suspected Martadiansyah,
Preterm estational age not in labor with susp plac  Prior CS 2x OB/Gyn ( C) – KFM
pregnancy with entae acreta + prior CS 2x single life fet  Complete Consult to surgery va
prior CS 2x us transverse lie placenta previa scular
 Single life fetus tr Consult to urology
History of abdominal contraction ansverse lie Plan for MRI
radiates to waist and become regular (-), Plan for Sectio Caesa
history of amniotic fluid leakage (-), ICD 10 rea hysterectomy
history of bloody show (-), history of Z3A.34 – 34 weeks
trauma (-), history of abdominal gestational age ICD 9
massage (-), history of post coital (-), O43.21 – placenta 57.31 – cystoscopy
history of consume traditional medicine accrete was
(-). suspected
O34.21 – maternal
Obstetrical examination
care for previous
External examination
CS
Uterine fundal height in ½ xyphoid
O44.03 – complete
process – umbilical (27cm), transverse
placenta previa
lie, contraction (-), FHR 141x/minute,
O32.2 – maternal
EFW 2321 gram
care for transverse
and oblique lie
Supporting examination
US result (08.02.2021)
 34 weeks gestational age, Single life
fetus transverse lie
Complete placenta previa
Placenta accrete was suspected ( PAI
Score 9  probability 90%)

2 Mrs. EKA/ 27 08.02.2021  G4P2A1 20 weeks Other therapy

YO/ 1196859/ Patient came to fetomaternal outpatient gestational age according to internal
PALEMBANG/ clinic for pregnancy control, referred  Nephrotic medicine assessment
MTN-TIA/AB from Dr. Suparti, SpPD with diagnosed syndrome caused Laboratory
G4P2A1 19 weeks gestational age with by GNAPS was examination
Preterm pregnanc nephrotic syndrome caused by GNAPS suspected dd/  FeSO4 1x1
y with swelling of dd/ lupus nephritis. lupus nephritis  Folic Acid 3x1
the legs  Single life fetus CaCO3 1x1
History of abdominal contraction intrauterine
radiates to waist and become regular (-), ICD 9
history of amniotic fluid leakage (-), ICD 10 V72.62 – routine
history of bloody show (-). Patient Z3A.21 – 21 weeks laboratory
admitted has normal defecation with less gestational age examination
urination. N04.9 – Nephrotic 99.21 – infusion of
syndrome therapeutic substance
( unspecific)
Obstetrical examination
External examination
Uterine fundal height hard to assess, free
fluid sign (+), shifting dullness (+),
contraction (-), FHR (+)

Supporting examination
US examination ( 08.02.2021)
20 weeks gestational age, SLF
intrauterine
Right now, there is no sign of maternal-
fetal-placenta hypoperfusion
3 Mrs. SIT/ 39 08.02.2021  G7P2A4 32 weeks Control ( March, 08th
YO/ 197077/ Patient was referred from Prabumulih gestational age 2021)
PRABUMULIH/ Hospital with diagnosed G7P2A4 28-29  Bad obstetric  FeSO4 1x1
MTN-TIA/ AB weeks gestational age, Single life fetus history  Folic Acid 3x1
intrauterine with omphalocele.  Single life fetus CaCO3 1x1
Preterm cephalic
pregnancy with History of abdominal contraction presentation ICD 9
congenital radiates to waist and become regular (-),  Congenital 99.21 – infusion of
anomaly history of amniotic fluid leakage (-), anomaly therapeutic substance
history of bloody show (-).
ICD 10
Z3A.32 – 32 weeks
Obstetrical examination
gestational age
External examination
O09.299 –
Uterine fundal height in 3 fingers below
supervision for
xyphoid process ( 28 cm), longitudinal
BOH
lie, right fetal spine, cephalic, U 5/5,
Q89.9 – congenital
 contraction (-), FHR 155x/minute, EFW malformation
2480 gram

Supporting examination
US result ( 08.02.2021)
32 weeks gestational age, SLF cephalic
presentation with multiple congenital
anomaly ( omphalocele, flat head,
tricuspid regurgitation)
4 Mrs. DES/ 29 08.02.2021  G5P2A2 36 weeks Control ( February,
YO/ 995476/ Patient came to fetomaternal outpatient gestational age 15th 2021)
PALEMBANG/ clinic for pregnancy control. Patient has not in labor  FeSO4 1x1
MTN-TIA/ AF been hospitalized at Moh. Hoesin  Twin life fetus  Folic Acid 3x1
Hospital on Janaury 17th- 30th 2021 with cephalic-cephalic CaCO3 1x1
Preterm threatened preterm labor + covid-19 presentation
pregnancy with ( confirmed). ICD 9
twin life fetus ICD 10 99.21 – infusion of
History of abdominal contraction Z3A.36 – 36 weeks therapeutic substance
radiates to waist and become regular (-), gestational age
history of amniotic fluid leakage (-), O30.003 – twin
history of bloody show (-). pregnancy

Obstetrical examination
External examination
Uterine fundal height in 3 fingers below
xyphoid process ( 41 cm), longitudinal
lie- longitudinal lie, right-left fetal spine,
cephalic – cephalic, contraction (-), FHR
I 142x/minute; FHR II 151x/minute

Supporting examination
US result ( 08.02.2021)
36 weeks gestational age, twin life fetus
cephalic-cephalic presentation
5 Mrs. IND/ 29 08.02.2021  G3P2A0 14 weeks FeSO4 1x1
YO/ 845134/ Patient came for pregnancy control gestational age  Folic Acid 3x1
PALEMBANG/ consulted from renal-hypertensive  Prior CS 1x  CaCO3 1x1
MTN-TIA/RS division.  CKD stage V on Joint conference
HD Aspilet 80mg 1x 1
Preterm History of abdominal pain (-), history of  Single life fetus Hemodialysis 2x/wee
pregnancy with nausea and vomit (-), history of vaginal intrauterine ks
renal disease bleeding (-), history of tensed breast (+). Control every weeks
ICD 10
Z3A.14 – 14 weeks ICD 9
Past illness history 99.21 – infusion of
gestational age
 Patient has been diagnosed with O34.21 – maternal therapeutic substance
chronic kidney disease since 2017 care for previous
 In her 2nd pregnancy (2014), patient CS
had eclampsia antepartum in 24 weeks N18.5 – CKD stage
gestational age. Patient had seizure V
with high ureum value, and directly
 underwent HD and continued with
LSCS 2 days after HD. After
termination, patient treated at ICU and
done HD 1x
 7 days after HD, CDL was released
 Patient routinely control at renal-
hypertensive division and routinely
consume antihypertension and folic
acid
 In September, 2017 patient had anemia
and advice for PRC transfusion, and
found patient had high ureum value >
18. Patient than continued with routine
HD (Wednesday – Saturday) since
September, 2017 – now
 In 2014, patient done IUD insertion
and release it in 2018. In 2020 patient
got pregnant

Obstetrical examination
External examination
Uterine fundal height in 1 fingers above
symphysis, ballottement externa (+),
free fluid sign (-) FHR (+)

Supporting examination
US result ( 08.02.2021)
13 weeks gestational age, Single life
fetus intrauterine

6 Mrs. RAH/ 31 08.02.2021 G5P4A0 6 weeks ges Control ( 10 weeks

YO/ 727989/ Patient came to fetomaternal outpatient tational age, Intraut later)
PALEMBANG/ clinic. Patient admitted know her erine  Folic Acid 3x1
MTN-TIA/ AW pregnancy in January, 28th 2021. History
of tensed breast (+), history of headache ICD 9
Early pregnancy (-). ICD 10 99.21 – infusion of
Z3A.6 – 6 weeks therapeutic substance
gestational age
Patient admitted has late in menstruation
for 1 month

Obstetrical examination
External examination
Flat, supple, symmetrical, uterine fundal
height unpalpable, tenderness (-), free
fluid sign (-), ballottement externa (-)

Supporting examination
US result
6 weeks gestational age, Intrauterine
 Tuesday, February 9th 2021

No Identity Analysis Diagnosis Procedure

1 Mrs. TET/ 35 09.02.2021  G3P2A0 24 weeks  Control ( February,
YO/ 1197156/ Patient was come referred from Dr. gestational age 23rd 2021)
OKU TIMUR/ Mustika, OB/Gyn with diagnosed  Twin life fetus  Folic acid 1x1
MTN-TIA/ AB G3P2A0 28 weeks gestational age, cephalic  FeSO4 1x1
Twin life fetus cephalic-cephalic presentation – CaCO3 1x1
Preterm presentation, with congenital anomaly transverse lie
pregnancy with in 2nd fetus ( labio-palatochisis +  Multiple congenital ICD 9
twins and umbilical cord cyst). anomaly on fetus II 99.21 – infusion of
umbilical cord therapeutic substance
abnormality Past illness history ICD 10
History of antenatal care 4x with Z3A.24 – 24 weeks
midwife gestational age
History of antenatal care 1x with O30 – multiple
OB/Gyn gestation
Q89.9 – congenital
Obstetrical examination malformation
External examination
Uterine fundal height in 2 fingers
below xyphoid process ( 34 cm),
longitudinal - longitudinal lie, right-
left fetal spine, cephalic, FHR I
134x/minute; FHR II 156x/minute

Supporting examination
US result ( 09.02.2021)
24 weeks gestational age, with twin
life fetus ( monochorion diamniotic )
cephalic presentation – transverse lie
with fetal II : IUGR; Umbilical cyst
and multiple congenital anomaly ~
chromosomal anomaly was suspected
2 Mrs. DIA/ 28 09.02.2021  G3P2A0 15 weeks  Control ( March, 09th
YO/ 512778/ Patient came for pregnancy control. gestational age 2021)
PALEMBANG/  Prior CS 2x  Folic acid 1x1
MTN-TIA/ HI History of abdominal pain (-), history  Single life fetus  FeSO4 1x1
of vaginal bleeding (-), history of intrauterine CaCO3 1x1
Pregnancy control lecuorrhea (-), history of trauma (-),
history of consume traditional ICD 10 ICD 9
medicine (-). Z3A.15 – 15 weeks 99.21 – infusion of
gestational age therapeutic substance
Past illness history O34.21 – maternal
Hospitalized at Moh. Hoesin Hospital care for previous CS
on December, 28th 2020 caused by
hyperemis gravidarum

Obstetrical examination
External examination
Uterine fundal height in ½ umbilical –
xyphoid process, ballottement external
(+)

Supporting examination
US result ( 09.02.2021)
15 weeks gestational age, SLF
intrauterine

Wednesday, February 10th 2021

Thursday, February 11th 2021

FAMILY PLANNING OUTPATIENT REPORT

Friday, February 5th 2021

No Identity Analysis Diagnosis Procedure
1 Mrs. DEW/ 27 Y 04.02.2021  G3P0A2 16 weeks  Control ( February,
O/ 857301/ MUA Patient was consulted from internal gestational age 19th 2021)
RA ENIM/ DPR- medicine department with diagnosed  Systemic lupus  Aspilet 150 mg
EZA/ NS G3P0A2 preterm pregnancy with SLE. erythematous  CaCO3 3x1
 Hypertension stage Folid acid 1x1
Preterm History of abdominal pain (-), history
II  FeSO4 1x1
pregnancy with of vaginal bleeding (-), history of
systemic lupus amniotic fluid leakage (-). History of  Single life fetus Vitamin D 1x4
erythematous trauma (-), history of consume intrauterine
traditional medicine (-). ICD 9
ICD 10 99.21 – infusion of
Past Illness History Z3A.16 – 16 weeks therapeutic substance
Patient has been diagnosed with SLE gestational age
since 2014 and routinely consume M32.9 – systemic
methylprednisolone, simarc, and lupus erythematous
sandimun I10 – essential
hypertension
Physical examination
BP: 160/100 mmHg Internal medicine
Obstetrical examination assessment
Uterine fundal height in 1/2 umbilical- ( 04.02.2021)
symfisis( 12 cm), ballottement externa A.
(+), FHR (+), SLE
G3P0A2
Supporting examination Hypertension stage II
Lab result ( 04.02.2021)
Hb 12,2 g/dL RBC 4040/mm3 WBC P/
9000/mm3 HT 36% PLT 214000/µL HCQ 1x200 gram
MCV 88,9 fL MCH 30 pg MCHC 34 Aspilet 1x80 mg
g/dL RDW-CV 18,90% D/C CaCO3 3x500 mg
0/0/84/12/4 Ca 9,5 mg/dL SGOT 30 Methylprednisolon
U/L SGPT 15 U/L Albumin 3,0 g/dL 1x8 gram
Uric acid 6,1 gm/dL Na 132 mEg/L K Imuran 1x50 gram
4,7 mEg/L Lansoprazole 1x30
mg
US Examination ( 05.02.2021) Folic acid 3x5 mg
16 weeks gestational age, SLF Methyldopa 3x25
Intrauterine gram
Notching (+) bilateral OB/Gyn consult
PE potention
2 Mrs. ANI/ 31 Y 04.02.2021  G3P2A0 11 weeks  Control ( March, 09th
O/ 1179919/ PA Patient was referred from Pelabuhan gestational age 2021)
LEMBANG/ DP Hospital with diagnosed G3P2A0 11  Single life fetus  Folic acid 1x1
R-EZA/ AW weeks gestational age, with history of intrauterine
 CaCO3 3x1
CMV, HSV and rubella infection in
Pregnancy control previous pregnancy.  FeSO4 1x1
ICD 10 Laboratory
with HSV, CMV Z3A.11 – 11 weeks
and rubella History of abdominal contraction gestational age examination
infection in radiates to waist and become regular
previous (-), history of leucorrhea (-), history of ICD 9
pregnancy bloody show (-), history of abdominal 99.21 – infusion of
massage (-). therapeutic substance
V72.62 – routine
Past illness history laboratory
History of antenatal care with OB/Gyn examination
at Pelabuhan Hospital 1x/month

Obstetric history
1. 2013, female, preterm, 2400
gram, spontaneous delivery,
 Monday, February 8th 2021

Tuesday, February 9th 2021

Wednesday, February 10th 2021

Thursday, February 11th 2021

LACTATION AND PUERPERAL OUTPATIENT REPORT

Friday, February 5th 2021

Monday, February 8th 2021

Tuesday, February 9th 2021

Wednesday, February 10th 2021

Thursday, February 11th 2021

 HIDDEN
OBSTETRIC OUTPATIENT REPORT

Friday, February 5th 2021

Monday, February 8th 2021

Tuesday, February 9th 2021

Wednesday, February 10th 2021

Thursday, February 11th 2021

FAMILY PLANNING OUTPATIENT REPORT

Friday, February 5th 2021

Monday, February 8th 2021

Tuesday, February 9th 2021

Wednesday, February 10th 2021

Thursday, February 11th 2021

LACTATION AND PUERPERAL OUTPATIENT REPORT

Friday, February 5th 2021

Monday, February 8th 2021

Tuesday, February 9th 2021

Wednesday, February 10th 2021

Thursday, February 11th 2021